Clinical Trial

Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Calcitonin gene-related peptide (CGRP) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether CGRP administration can trigger aura in individuals with a diagnosis of migraine with aura.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-06.
Trial Details
NCT Number NCT07021859
Lead Sponsor Danish Headache Center
Conditions Migraine Aura, Migraine With Aura
Enrollment 21 participants
Start Date 2025-06-27
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-06